Navigation Links
Study paves way for development of macular degeneration cures

January 28, 2008 Owings Mills, MD -- A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.

This is the first time that scientists have been able to create an AMD animal model that closely represents the disease in people, said Stephen Rose, Ph.D., Chief Research Officer, Foundation Fighting Blindness. Though there are some treatments for the wet form of AMD, we still dont have a cure for the condition, and millions of people are still at risk of losing their vision to both the dry and wet forms. This new model will greatly enhance the development of better treatments and potentially a cure.

Researchers at the Cleveland Clinic Lerner College of Medicine used oxidative chemicals to sensitize the immune systems in mice and create AMD . The study is titled Oxidative damage-induced inflammation initiates age-related macular degeneration, and was published in the online edition of the scientific journal Nature Medicine on January 27.

Once developed, therapies for the dry form, or early stage of AMD, could be implemented before vision is lost, which would be a dramatic breakthrough in the treatment of the disease, Rose said.


Contact: David Harrison
Foundation Fighting Blindness

Page: 1

Related medicine news :

1. Study Challenges New Benchmark for High-Volume Heart Transplant Hospitals
2. Samarion(SM) Announces Formation of Outcome Based Study Team for Industrys Only Enterprise Quality Improvement System
3. Study Finds Both Coated Stents Perform the Same
4. Pancreatic cancer: The smaller the tumor, the better your chances, study shows
5. Study Links Snoring to Chronic Bronchitis
6. Study finds genetic link to human herpes susceptibility
7. Researchers at Peoria Pulmonary Associates to study airway bypass procedure for emphysema
8. New study finds resistant organisms at core of soft contact lens corneal infections
9. Feds fund study of drug that may prevent radiation injury
10. Study examines self-expanding plastic stents in the treatment of benign esophageal conditions
11. Amalgam Fillings Dont Affect Childrens Brain Development, Says Study in ADA Journal
Post Your Comments:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
(Date:6/23/2016)... , June 23, 2016  Experian Health, ... and transforming the patient payment and care ... innovative new products and services that will ... revenue cycle offerings. These award-winning solutions will ... workflows, remain compliant in an ever-changing environment ...
Breaking Medicine Technology: